Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVAGOLD RESOURCES INC (NG)

  • Business News
  • May 01, 2026, 20:45 UTC
  • 2
  • 1 comments

NOVAGOLD Announces Date of Its 2026 Virtual Annual General Meeting of Shareholders

Market reaction Comment Full text

CANADIAN NATIONAL RAILWAY CO (CNI)

  • Business News
  • May 01, 2026, 20:45 UTC
  • 4
  • 1 comments

CN Announces Election of Directors

Market reaction Comment Full text

CANADIAN NATIONAL RAILWAY CO (CNI)

  • Business News
  • May 01, 2026, 20:45 UTC
  • 2
  • 1 comments

Le CN annonce l’élection des administrateurs

Market reaction Comment Full text

Equillium Inc. (EQ)

  • Business News
  • May 01, 2026, 20:42 UTC
  • 3
  • 1 comments

Equillium - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

EQUILLIUM, INC. (EQ)

  • Business News
  • May 01, 2026, 20:42 UTC
  • 1
  • 1 comments

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

RB GLOBAL INC. (RBA)

  • Business News
  • May 01, 2026, 20:40 UTC
  • 1
  • 1 comments

RB Global Reports on Voting Results From the 2026 Annual and Special Meeting of Shareholders

Market reaction Comment Full text

NEKTAR THERAPEUTICS (NKTR)

  • Business News
  • May 01, 2026, 20:39 UTC
  • 1
  • 1 comments

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

NATUZZI S P A (NTZ)

  • Business News
  • May 01, 2026, 20:36 UTC
  • 1
  • 1 comments

Natuzzi Filed Form 12B-25 for Late Filing of Form 20-F

Market reaction Comment Full text

MFS INTERMEDIATE INCOME TRUST (MIN)

  • Business News
  • May 01, 2026, 20:35 UTC
  • 1
  • 1 comments

MFS Government Markets Income Trust and MFS Intermediate Income Trust Announce Special Shareholder Meeting Relating to Proposed Appointment of Aberdeen Investments as Investment Adviser

Market reaction Comment Full text

VANDA PHARMACEUTICALS INC. (VNDA)

  • Business News
  • May 01, 2026, 20:35 UTC
  • 1
  • 1 comments

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

Market reaction Comment Full text
  • Previous
  • 205
  • 206
  • 207
  • 208
  • 209
  • Next

Search

News categories

  • Technical Exchange News(12315)
  • Event(6229)
  • SEC News(267781)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155963)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin